Crunching the numbers for LYB... Refresh in a moment for the full analysis.
LyondellBasell Industries N.V. (LYB)
Healthcare
weak
$73.72
Updated: 2026-04-12
37
TradeApes Score
reduce
Financial Strength
20
Stressed
Operating Trend
20
Stressed
Valuation
50
Mixed
Capital Allocation
45
Mixed
Risk
80
Strong
Key Findings
+
Low stock compensation — SBC below 3% of revenue
−
Very high leverage — net debt/EBITDA above 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.